|
nasdaq:vvus
|
439767
|
Apr 28th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 28th, 2024 01:30AM
|
Apr 28th, 2024 01:30AM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 27th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 26th, 2024 11:50PM
|
Apr 26th, 2024 11:50PM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 26th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 25th, 2024 11:57PM
|
Apr 26th, 2024 09:18AM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 25th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 24th, 2024 11:52PM
|
Apr 25th, 2024 07:31PM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 24th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 24th, 2024 12:00AM
|
Apr 24th, 2024 12:00PM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 23rd, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 22nd, 2024 11:41PM
|
Apr 22nd, 2024 11:41PM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 22nd, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 22nd, 2024 12:46AM
|
Apr 22nd, 2024 12:46AM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 21st, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 21st, 2024 03:27AM
|
Apr 21st, 2024 03:27AM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 20th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 20th, 2024 12:27AM
|
Apr 20th, 2024 05:49PM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:vvus
|
439767
|
Apr 19th, 2024 12:00AM
|
VIVUS LLC
|
3.6K
|
143.00
|
Open
|
|
Apr 19th, 2024 04:50AM
|
Apr 19th, 2024 04:50AM
|
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.
|
Open
|
BioPharma
|
Open
|
900 E Hamilton Ave
|
Campbell
|
California
|
US
|
95008
|
|
VIVUS
|
Health Care
|
Pharmaceuticals & Biotechnology
|